標(biāo)題: Titlebook: Lung Cancer; New Understandings a Anne C. Chiang,Roy S. Herbst Book 2021 Springer Nature Switzerland AG 2021 lung cancer.NSCLC.SCLC.lung ca [打印本頁] 作者: 海市蜃樓 時間: 2025-3-21 16:43
書目名稱Lung Cancer影響因子(影響力)
書目名稱Lung Cancer影響因子(影響力)學(xué)科排名
書目名稱Lung Cancer網(wǎng)絡(luò)公開度
書目名稱Lung Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Lung Cancer被引頻次
書目名稱Lung Cancer被引頻次學(xué)科排名
書目名稱Lung Cancer年度引用
書目名稱Lung Cancer年度引用學(xué)科排名
書目名稱Lung Cancer讀者反饋
書目名稱Lung Cancer讀者反饋學(xué)科排名
作者: glucagon 時間: 2025-3-21 21:04
Kelsey Sheehan,Kurt A. Schalper pro- as those that are still in investigational phases. cedures have become of great interest to the Clinical case reports are presented by expert in- cardiologist, radiologist, and cardiovascular vestigators on the use of various catheter systems surgeon. One of the most extensively explored in th作者: 斜 時間: 2025-3-22 02:02 作者: lethargy 時間: 2025-3-22 05:07
Daniel Morgenszternr mass spectrometer” (LAMS), whose essential new features consist of a pulsed, tunable-dye-laser ionization source and a gated-detection system for the mass-separated ions. Multiple photon ionization (MPI) spectra of isolated molecules are obtained via irradiation (by means of the pulsed, tunable la作者: acolyte 時間: 2025-3-22 12:42 作者: animated 時間: 2025-3-22 15:12
Michael J. Grant,Katerina Politi,Scott Gettingerr mass spectrometer” (LAMS), whose essential new features consist of a pulsed, tunable-dye-laser ionization source and a gated-detection system for the mass-separated ions. Multiple photon ionization (MPI) spectra of isolated molecules are obtained via irradiation (by means of the pulsed, tunable la作者: 不怕任性 時間: 2025-3-22 17:08 作者: 確定 時間: 2025-3-22 22:37 作者: 嫻熟 時間: 2025-3-23 05:23 作者: 舞蹈編排 時間: 2025-3-23 09:33
Vamsidhar Velcheti,David Schrump,Yogen Saunthararajaher in 1960, a steadily increasing number of applications has been found for this remarkable device. At first it appeared strangely difficult to fmd any obvious applications, and for several years the laser was often referred to as ‘a(chǎn) solution in search of a problem‘. The unusual properties of laser 作者: 遺忘 時間: 2025-3-23 10:46 作者: Ambiguous 時間: 2025-3-23 17:21 作者: Atrium 時間: 2025-3-23 20:34 作者: keloid 時間: 2025-3-24 01:07 作者: 努力趕上 時間: 2025-3-24 03:05
Immune Therapy: What Can We Learn From Acquired Resistance?,sponse to these agents can be durable, but most patients will go on to develop resistance after initial tumor regression or prolonged disease stability. In patients with ‘a(chǎn)cquired oligo-resistance,’ in whom progression is limited to two or less disease sites, local therapy may be an effective manage作者: 無力更進(jìn) 時間: 2025-3-24 10:16
Management of Brain Metastases, brain metastases is increasing. Lung cancer is the most frequent origin of metastases to the brain, and this diagnosis is associated with significant morbidity as well as decreased quality of life and a worse prognosis. The treatment for brain metastases in NSCLC has historically been local therapy作者: Type-1-Diabetes 時間: 2025-3-24 14:17 作者: Neutral-Spine 時間: 2025-3-24 16:14 作者: COM 時間: 2025-3-24 21:52
Small Cell Lung Cancer: Biology Advances,une checkpoint inhibitors have been approved for use in combination with etoposide plus a platinum agent as initial therapy for patients extensive stage SCLC; with the triplet regimen, the median overall survival is approximately 12?months. Over the past 4?years, several agents, including immune che作者: 使混合 時間: 2025-3-24 23:51 作者: 變量 時間: 2025-3-25 05:53 作者: analogous 時間: 2025-3-25 08:16 作者: Largess 時間: 2025-3-25 11:49
Current Cancer Researchhttp://image.papertrans.cn/l/image/589072.jpg作者: chemical-peel 時間: 2025-3-25 15:58 作者: 共和國 時間: 2025-3-25 22:21
978-3-030-74030-6Springer Nature Switzerland AG 2021作者: 泥土謙卑 時間: 2025-3-26 03:41
Lung Cancer978-3-030-74028-3Series ISSN 2199-2584 Series E-ISSN 2199-2592 作者: 欺騙手段 時間: 2025-3-26 06:50
Book 2021tegy that has yielded productive advances in the subsequent treatment.? Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement..作者: falsehood 時間: 2025-3-26 10:11
Book 2021 as in the overall management approach.? For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment.? Future advances also include incorporating biomarker data obtained from solid 作者: endocardium 時間: 2025-3-26 13:37 作者: Shuttle 時間: 2025-3-26 19:54
Liquid Biopsies: New Technology and Evidence,ted from dying cells, EVs originates from living cells and may provide a better evaluation of the cancer biology. Early studies have shown comparable sensitivity for EVs and ctDNA in the detection of targetable alterations. CTCs may be useful to evaluate the risk of tumor relapse after treatment with curative intention.作者: 暫時過來 時間: 2025-3-27 00:11 作者: Cloudburst 時間: 2025-3-27 04:19
Immunotherapy and Radiotherapy: New Strategies, its application has the potential to liberate tumor antigen in the context of pro-inflammatory cell death. This chapter describes interactions between radiotherapy and the immune system, with a particular focus on an emerging mechanistic understanding of how radiation can materially contribute to an anti-tumor immune response.作者: 傻瓜 時間: 2025-3-27 05:35
2199-2584 so include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement..978-3-030-74030-6978-3-030-74028-3Series ISSN 2199-2584 Series E-ISSN 2199-2592 作者: averse 時間: 2025-3-27 10:03 作者: Creatinine-Test 時間: 2025-3-27 13:36
Immune Therapy: What Can We Learn From Acquired Resistance?, defects in IFN- γ signaling, upregulation of alternative immune checkpoint pathways, and various tumor genomic or epigenetic changes have been implicated. In this review, we propose clinical criteria, highlight emerging management strategies, and discuss mechanistic insights into acquired resistance to PD-1 axis inhibitors in NSCLC.作者: 使顯得不重要 時間: 2025-3-27 18:03 作者: Hamper 時間: 2025-3-27 23:25 作者: 其他 時間: 2025-3-28 05:53
Small Cell Lung Cancer: Biology Advances,al regulators. These analyses are leading to a better understanding of SCLC biology and may help identify distinct therapeutic vulnerabilities among subsets of this disease. Ideally, these investigations will lead to more personalized therapeutic approaches and better outcomes for patients diagnosed with this aggressive cancer.作者: inchoate 時間: 2025-3-28 07:42
2199-2584 gy to inform clinical management in patients treated with im.Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach.? For targeted and immunotherapeutic approaches, un作者: 用不完 時間: 2025-3-28 13:55
aser systems are and follow-up data. A detailed description of available to the clinician and the researcher, laser recanalization techniques is presented for which often makes the choice of a laser system the various systems in the clinical setting.978-1-4612-8801-5978-1-4613-1489-9Series ISSN 0166-9842 作者: 羊欄 時間: 2025-3-28 15:45 作者: 小口啜飲 時間: 2025-3-28 22:50 作者: Lumbar-Spine 時間: 2025-3-29 01:13 作者: Hormones 時間: 2025-3-29 04:36 作者: Preserve 時間: 2025-3-29 08:34
